Collaborators
Past and current collaborators
Dr. Rob Laister
University Health Network
Dr. Berge Minassian
SickKids Hospital
Dr. Daniel Gough
Institute of Medicinal Research
Dr. William Muller
McGill Tyrosine kinase epidermal growth factor receptor (EGFR) family
Dr. Gurmit Singh
McMaster University Pathology and Molecular Medicine
Dr. Vinod Chandra
University of Toronto Laboratory Medicine and Pathology
Dr. Tony Mazzulli
University of Toronto Laboratory Medicine and Pathobiology
Dr. Shiela Singh
McMaster University, Medulloblastoma
Dr. Melissa Fishel
Indiana University, Pancreatic Cancer
Dr. Mark Minden
Princess Margaret Hospital, STAT5 in Leukemia
Dr. Len Luyt
Western University, 18F labelled inhibitors
Dr. Aaron Schimmer
Princess Margaret Hospital- Leukaemia Drug Discovery
Dr. Artee Luchman
University of Alberta, Glioblastoma
Dr. David Frank
Dana-Farber Cancer Institute, STAT3
Dr. Aubry Miller
German Cancer Research Center
Dr. Stefan N. Constantinescu
Ludwig Cancer Research
Dr. Sultan Darvesh
Dalhousie Division of Neurobiology
Dr. Michael Rudnicki
The Ottawa Hospital
Dr. Josh Milstein
University of Toronto, Biological Physics
Dr. Suzanne L. Trudel
Princess Margaret Hospital, STAT3 in Multiple Myeloma
Dr. Ulrich Krull
Nanotechnology and Fluidics for Bioassays and Theranostics
Dr. Sirano Dhe-Paganon
Dana-Farber Cancer Institute STAT3 and E1 enzyme
Dr. Sameul Asfaha
Western University, Inhibitors of Colitis
Dr. Sam Weiss
University of Alberta, Glioblastoma
Dr. Richard Moriggl
University of Vienna- STAT5 Inhibitor Research
Dr. Michael Deininger
Huntsman Cancer Research Institute, STAT3 inhibitors in CML